XP Inc. · XP · FY2026 Q3 · Calendar Q4 2026
XP’s Q3 growth centers on retail, offshore expansion and capital returns
XP’s latest call supports a growth case built on retail engagement, offshore expansion and fee-based services, while execution, market sensitivity and credit exposure remain important counterweights.
Research this report with FN2. Free to start; review your question before sending.
Earnings scorecard
Reported versus consensusMarket reaction
event-close to next-session closeAsk FN2 about XP FY2026 Q3
Choose a question to continue your researchFree to start. Your question opens in chat for you to review and send. FN2 can look up the transcript, financials and prior quarters.
Transcript intelligence
What changed
Compared with the prior quarter’s discussion, management emphasized further offshore-platform penetration, additional SMB and integrated offerings, and a newly announced buyback. The 2027 revenue-growth target was maintained, with operating leverage still a stated objective.
Guidance delta
Management maintained its target of about 10% revenue growth in 2027 and described plans to improve operating leverage. It also cited a net-new-money objective of around BRL 20 billion in the supplied call analysis.
Key takeaways
- Management attributed growth to retail activity, platform offerings and newer business lines.
- Offshore assets and fee-based advisory remain strategic growth areas, but offshore still represents a small share of client assets.
- Capital returns are substantial; investors should weigh them against the capital demands of expanding credit and platform offerings.
Management priorities
- Expand offshore offerings and increase client penetration.
- Develop SMB and integrated products, while investing in technology and AI.
- Pursue operating leverage and manage capital while returning funds to shareholders.
Follow XP with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Analyst 52W Price Targets
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Nov 22, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Goldman Sachs | Buy | Buy | Maintain | Nov 12, 2026 |
| UBS | Buy | Buy | Maintain | Nov 5, 2026 |
| Citigroup | Neutral | Buy | Downgrade | Oct 27, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Oct 6, 2026 |
| Itau BBA | Outperform | Market Perform | Upgrade | Oct 6, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | May 21, 2025 |
| Morgan Stanley | Overweight | Equal Weight | Upgrade | May 13, 2025 |
| Banco Bradesco BBI S.A | Outperform | Neutral | Upgrade | Jan 24, 2024 |
| Credit Suisse | Neutral | Underperform | Upgrade | Jul 20, 2023 |
| HSBC | Buy | Buy | Maintain | Feb 28, 2023 |
Named analyst price targets
Upside is calculated against the persisted current price $13.13. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Banco Santander | Analyst unavailable | $19 | $16.09 | +44.7% | Oct 29, 2026 |
| Morgan Stanley | Analyst unavailable | $23 | $16.09 | +75.2% | Oct 29, 2026 |
| Morgan Stanley | Jorge Kuri | $19 | $16.09 | +44.7% | Oct 29, 2026 |
| Citigroup | Gustavo Schroden | $15 | $15.96 | +14.2% | Oct 27, 2026 |
| Bank of America Securities | Analyst unavailable | $33 | $31.34 | +151.3% | Oct 20, 2026 |
| UBS | Analyst unavailable | $37 | $30.44 | +181.8% | Oct 8, 2026 |
| Jefferies | Analyst unavailable | $22 | $17.4 | +67.6% | Jan 19, 2026 |
| UBS | Thiago Batista | $25 | $17.58 | +90.4% | Dec 16, 2025 |
| UBS | Thiago Batista | $23 | $16.53 | +75.2% | Oct 16, 2025 |
| UBS | Thiago Batista | $21 | $18.25 | +59.9% | Jul 11, 2024 |
| Bradesco | Gustavo Schroden | $19 | $16.7 | +44.7% | Jul 2, 2024 |
| Goldman Sachs | Tito Labarta | $23 | $21.42 | +75.2% | Apr 30, 2024 |
| Morgan Stanley | Jorge Kuri | $24 | $21.11 | +82.8% | Apr 22, 2024 |
| Bradesco | Otavio Tanganelli | $32 | $25.47 | +143.7% | Jan 24, 2024 |
| Credit Suisse | Marcelo Telles | $26 | $23.82 | +98.0% | Jul 20, 2023 |
| HSBC | Neha Agarwala | $33 | $20.48 | +151.3% | Jun 10, 2022 |
Track every rating change on XP the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationXP Inc. provides financial products and services in Brazil. The company operates XP Platform, an open product platform that provides clients to access investment products in the market comprising brokerage securities, fixed income securities, mutual, hedge, and private equity funds; derivatives and synthetic instruments; credit cards; loan operations/collateralized credit products; pension and social security funds, and life and travel insurance products; and other investment products comprising real estate funds, and equity and debt capital markets solutions, as well as wealth management services. It offers brokerage and issuer services to institutional and corporate clients.…
Historical context
All XP earningsFinancial Services peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| FUTU Futu Holdings Limited | FY2026 Q3 · Calendar Q4 2026 | -7.8% | +4.8% | Futu’s Q3 shows strong client inflows, but guidance remains unspecified |
| BN Brookfield Corporation | FY2026 Q3 · Calendar Q4 2026 | -6.1% | -1.0% | Brookfield’s Q3 earnings rose as fundraising and Wealth Solutions gained traction |
| NU Nu Holdings Ltd. | FY2026 Q3 · Calendar Q4 2026 | -2.8% | -4.0% | Nu reports record Q3 revenue as credit and international expansion grow |
Latest beats and misses
Who reports nextBeat on EPS
- INTUFY2027 Q1 · November 19, 2026+18.3% EPS-6.2% move
- ROSTFY2026 Q3 · November 19, 2026+2.1% EPS-2.8% move
- ESTCFY2027 Q2 · November 19, 2026+16.2% EPS+2.0% move
- KEYSFY2026 Q4 · November 19, 2026+7.1% EPS-1.5% move
- WSMFY2026 Q3 · November 19, 20260.0% EPS-15.2% move
- WMGFY2026 Q4 · November 19, 2026+50.9% EPS-0.6% move
Missed on EPS
- NTESFY2026 Q3 · November 19, 2026-12.8% EPS-11.4% move
- FUTUFY2026 Q3 · November 19, 2026-7.8% EPS+4.8% move
- BABAFY2027 Q2 · November 19, 2026-29.2% EPS-1.3% move
- SQMFY2026 Q3 · November 17, 2026-3.0% EPS-5.5% move
- VIKFY2026 Q3 · November 17, 2026-12.6% EPS+4.4% move
- XPEVFY2026 Q3 · November 16, 2026-26.5% EPS+3.2% move
Get the XP recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-11-17T15:17:21.166198+00:00
- FN2 earnings calendar · 2026-11-17T01:23:14.281446+00:00
- Polygon adjusted daily market bars · 2026-11-17T15:20:43.722657+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-11-17T15:20:43.719983+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-11-17. For educational purposes only; not investment advice.